Insulin-delivery device maker Valeritas (NSDQ:VLRX) missed earnings and revenue expectations on Wall Street with its 1st quarter results. The Bridgewater, N.J.-based company pared its losses to -$11.9 million on sales of $4.6 million for the 3 months ended March 31, for bottom-line growth of 30% on sales loss of -8% compared with the same period last year. […]
Amid drug-pricing criticism, industry trade group ousts members
The pharmaceutical industry’s trade group ousted 22 companies earlier this week after it revised membership rules. The move comes as lawmakers in Washington have pressed the pharma industry about U.S. drug prices. The updated membership rules for the Pharmaceutical Research and Manufacturers of America (PhRMA) group mandates that members spend at least $200 million each year […]
NanoMedical Systems raises $4.1m
NanoMedical Systems raised $4.1 million in a new round of financing, according to a regulatory filing. The Delaware-based company offered equity and warrants to the 46 investors that contributed to the round. The company did not disclose how it plans to use its newly-acquired funds. No money from the round is slated to compensate sales […]
Senseonics, TypeZero ink development deal for artificial pancreas
Senseonics (NYSE:SENS) said yesterday that it inked a non-exclusive R&D license agreement with TypeZero Technologies to develop artificial pancreas and decision support systems for its Eversense continuous glucose monitor. The companies plan to integrate glucose readings from the Eversense system with TypeZero’s inControl artificial pancreas algorithms to regulate insulin delivery through a user’s insulin pump. […]
Researchers use shock waves, nanoparticles to deliver chemo drugs
Researchers from the University of Turin demonstrated that combining shock waves with nanoparticles can help deliver chemotherapy to tumors in animal models. The team’s work was published in the journal, Endocrine-Related Cancer. Researchers designed the treatment to use extracorporeal shock waves and nanobubbles to more effectively target the cancer drugs to the tumor site. The team […]
Clearside Biomedical beats Q1 earnings consensus
Shares in Clearside Biomedical (NSDQ:CLSD) rose today after the biopharmaceutical company met expectations on Wall Street with its 1st quarter results. The Alpharetta, Ga.-based company posted a net loss of -$10.4 million, or -41¢ per share, on sales of $5,000 for the 3 months ended March 31, for bottom-line loss of -47.5 % compared with […]
HRS 2017: First ever nasal spray used to treat rapid heart rate condition
Data from a 100-patient clinical trial showed that a fast-acting nasal spray therapy, etripamil, was effective at stopping a common rapid heart rate condition, researchers said today at the annual Heart Rhythm Society conference in Chicago. Paroxysmal supraventricular tachycardia is traditionally treated with adenosine, calcium channel blockers or beta blockers, which is administered using an IV […]
Propeller Health: From hardware startup to analytics leader
Seven years after the digital respiratory startup Propeller Health launched, co-founder and chief technology officer Greg Tracy told a crowd at this year’s Medical Sensors Design Conference that what started as an attempt to build sensors for respiratory devices has slowly evolved into a “hardware-enabled software company.” “We thought that we were going to go build […]
Bellerophon raises $3m in direct offering
Bellerophon Therapeutics (NSDQ:BLPH) said yesterday that it inked a $3 million direct offering of common stock with a single, unnamed institutional investor. The offering is expected to close by the beginning of next week. Warren, N.J.-based Bellerophon plans to issue 2 million registered shares of common stock at $1.50 apiece in connection with the offering. […]
Teva beats estimates for Q1 earnings
Shares in Teva Pharmaceutical (NYSE:TEVA) fell slightly in pre-market activity today after the pharmaceutical company beat earnings expectations on Wall Street with its 1st quarter results. The Israel-based company posted profits of $641 million on sales of $5.63 billion for the 3 months ended March 31, for bottom-line growth of 1.3% on sales growth of 17% compared […]